Patient Square Capital »

Dianthus Therapeutics shares owned by Patient Square Capital

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Patient Square Capital from 13F filings

Historical chart of Patient Square Capital investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Patient Square Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.9M 125k 39.35

More positions owned by Patient Square Capital

Roivant Sciences SHS (ROIV)
Insmed Com Par $.01 (INSM)
Eyepoint Pharmaceuticals Com New (EYPT)
Abivax Sa Sponsored Ads (ABVX)
Cidara Therapeutics Com New (CDTX)
Argenx Se Sponsored Adr (ARGX)
Liquidia Corporation Com New (LQDA)
Pharvaris N V (PHVS)
Ocular Therapeutix (OCUL)
Mirum Pharmaceuticals (MIRM)
Agios Pharmaceuticals (AGIO)
Kymera Therapeutics (KYMR)
Enliven Therapeutics (ELVN)
Celcuity (CELC)
Dianthus Therapeutics (DNTH)

View all positions for Patient Square Capital

Top funds holding Dianthus Therapeutics

FMR
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Point72 Asset Management
TCG Crossover Management
Vanguard Group
BlackRock
Bain Capital Life Sciences Investors
Vestal Point Capital
Citadel Advisors
VR Adviser
Alliancebernstein

View all funds holding Dianthus Therapeutics